Does VALACYCLOVIR Cause Interstitial lung disease? 126 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Interstitial lung disease have been filed in association with VALACYCLOVIR (Valacyclovir Hydrochloride). This represents 1.0% of all adverse event reports for VALACYCLOVIR.
126
Reports of Interstitial lung disease with VALACYCLOVIR
1.0%
of all VALACYCLOVIR reports
3
Deaths
60
Hospitalizations
How Dangerous Is Interstitial lung disease From VALACYCLOVIR?
Of the 126 reports, 3 (2.4%) resulted in death, 60 (47.6%) required hospitalization, and 11 (8.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALACYCLOVIR. However, 126 reports have been filed with the FAERS database.
What Other Side Effects Does VALACYCLOVIR Cause?
Acute kidney injury (978)
Drug ineffective (894)
Off label use (593)
Pyrexia (551)
Drug reaction with eosinophilia and systemic symptoms (496)
Confusional state (456)
Rash (423)
Nausea (415)
Neurotoxicity (404)
Altered state of consciousness (395)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which VALACYCLOVIR Alternatives Have Lower Interstitial lung disease Risk?
VALACYCLOVIR vs VALBENAZINE
VALACYCLOVIR vs VALBENAZINE DITOSYLATE
VALACYCLOVIR vs VALDECOXIB
VALACYCLOVIR vs VALERIAN
VALACYCLOVIR vs VALGANCICLOVIR